EpiEndo Pharmaceuticals is Drug Discovery in Iceland that focus on proprietary compounds business. Founded in 2014. They cover business area such as developer, drug, proprietary compound, new treatment, chronic airway disease, novel, azithromycin, epithelial dysfunction, inflammation, chronic respiratory disease, healthcare professional, patient, their life.
2014
( 12 years old in 2026 )
Proprietary Compounds
-
Eiðistorg 13-15
3rd floor
Seltjarnarnes, 170
Iceland
Private
developerdrugproprietary compoundnew treatmentchronic airway diseasenovelazithromycinepithelial dysfunctioninflammationchronic respiratory diseasehealthcare professionalpatienttheir life
* We use standard office opening hours in near EpiEndo Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EpiEndo Pharmaceuticals is Drug Discovery business from Iceland that founded in 2014 (12 years old in 2026), EpiEndo Pharmaceuticals business is focusing on Proprietary Compounds.
EpiEndo Pharmaceuticals headquarter office and corporate office address is located in Eiðistorg 13-15 3rd floor Seltjarnarnes, 170 Iceland.
EpiEndo Pharmaceuticals was founded in Iceland.
In 2026, EpiEndo Pharmaceuticals is currently focus on proprietary compounds sector.
Above is snippet of Google Trends for "proprietary compounds" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EpiEndo Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
